Covaris and Illumina to Co-Market Sample-Prep Tools, Sequencers | GenomeWeb

Covaris said this week that it has signed a co-marketing agreement with Illumina under which the companies will co-market Covaris' DNA shearing technology with Illumina's sequencing product line, including the Genome Analyzer, HiSeq 2000, and HiScanSQ.

Financial details of the deal were not disclosed.

The Covaris system is used to prepare samples for sequencing. According to the company, its technology "enables higher recoveries for nucleic acid extraction, tissue homogenization, chromatin shearing, protein digestion, and cell lysis."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.